Absolute
binding free-energy (ABFE) calculations are playing an
increasing role in drug design, especially as they can be performed
on a range of disparate compounds and direct comparisons between them
can be made. It is, however, especially important to ensure that they
are as accurate as possible, as unlike relative binding free-energy
(RBFE) calculations, one does not benefit as much from a cancellation
of errors during the calculations. In most modern implementations
of ABFE calculations, a particle mesh Ewald scheme is typically used
to treat the electrostatic contribution to the free energy. A central
requirement of such schemes is that the box preserves neutrality throughout
the calculation. There are many ways to deal with this problem that
have been discussed over the years ranging from a neutralizing plasma
with a post hoc correction term through to a simple co-alchemical
ion within the same box. The post hoc correction approach is the most
widespread. However, the vast majority of these studies have been
applied to a soluble protein in a homogeneous solvent (water or salt
solution). In this work, we explore which of the more common approaches
would be the most suitable for a simulation box with a lipid bilayer
within it. We further develop the idea of the so-called Rocklin correction
for lipid-bilayer systems and show how such a correction could work.
However, we also show that it will be difficult to make this generalizable
in a practical way and thus we conclude that the use of a “co-alchemical
ion” is the most useful approach for simulations involving
lipid membrane systems.